Ashurst advises CPT Capital on series C investment in foodtech company ENOUGH
23 August 2023
Global law firm Ashurst has advised CPT Capital on its co-lead series C investment in 3F Bio Ltd (trading as ENOUGH), a foodtech company that produces mycoprotein for use in the replication of meat, egg and dairy food products.
ENOUGH, a biotechnology company that specialises in high-scale biomass fermentation, has secured a further €40 million in growth funding, co-funded by CPT Capital and World Fund, and other existing shareholders. This brings the total capital raised by ENOUGH to over €95 million. The funding will be used to scale up capacity at its factory in the Netherlands and to internally grow its teams across offices in Glasgow, London and Sas van Gent.
The Ashurst team was led by corporate transactions partners Dallan Pitman and Braeden Donnelly and associate Ariella Moses.
